Cardiovascular Health Promotion and Disease Prevention in China Authors: Xi Li, Jun Lv, An Pan, Yuan Lu, Jun Cai, Jing Li, Jiapeng Lu, Xiangfeng Lu, Zengwu Wang, Haibo Zhang, Yaohua Tian, Chunying Lin, Yi Wu, Zhiyi Chen, Shengshou Hu Published: 2026 ABSTRACT China has prioritized the prevention of cardiovascular disease. Over the past decade, significant investments have been made in public health services, along with the implementation of various health promotion policy agendas. As a result, environmental cardiovascular hazards have been substantially reduced, and care coverage within the primary health care system has improved. Nevertheless, adherence to various healthy lifestyles within the population has exhibited different secular trends, meanwhile the underutilization of secondary prevention medications among vulnerable populations is concerning. The Healthy China Initiative 2030 outlines a roadmap to prevent, pre-empt, and mitigate cardiovascular disease. China, along with other developing countries facing similar challenges, should consider fostering supportive social environments for healthy behaviors, targeting vulnerable groups for lifestyle adherence and access to care, expanding the scope of services provided by primary care providers, leveraging new technologies to develop scalable tools, and integrating surveillance systems for health promotion and care. Cardiovascular disease (CVD) is the leading and a growing cause of morbidity and mortality in China, a large developing country experiencing rapid urbanization and population aging. From 1990 to 2019, the estimated number of individuals suffering from CVD in China more than doubled, rising from 50.1 million to 120.3 million (Supplemental Figure 1A). During the same period, the crude mortality rate of stroke and coronary heart disease increased from 167 to 286 per 100,000 persons (Supplemental Figure 1B) which is already 40% higher than the global average. Moreover, the growth in total expenditure on CVD treatment in China has outpaced the increase in gross domestic product.1 Therefore, the burden of CVD has become a critical factor affecting not only population health, but also the sustainable development of society in China. Implementing a consistent health policy of “focusing on grassroots and prioritizing prevention,” China has been coordinating government investment and social initiatives since the late 1960s, aiming to reverse the upward trend of CVD burden. Particularly in the past decade, CVD prevention has become an integral part of the government-funded Basic Public Health Service (BPHS) project (Supplemental Table 1). In the Healthy China initiative (2019-2030), launched in 2019, the government emphasized CVD prevention and control as a priority among major diseases.2 It called for the involvement of all government sectors, the entire society, and every individual in this effort. Nevertheless, a retrospective analysis of the current status and challenges in CVD prevention in China is essential for informing future strategies. In this narrative review, we summarize the data and evidence regarding CVD prevention in China. Based on the well-established findings on the leading CVD risk factors (Supplemental Figure 2) and the management of them, we developed an assessment framework to structure our summary (Figure 1), which encompasses 2 key aspects: 1) the Lifestyle and Environment Improvement section, which focuses on behavioral and environmental risk factors; and 2) the Preventive Care section, which includes both primary and secondary prevention. Additionally, we analyze the systematic challenges and provide new insights for future policy improvement in the Recommendations section.Figure 1Causal Chains of Cardiovascular Disease and PreventionModified based on the WorldHealth Report 2002—Reducing Risks, Promoting Healthy Life.86 CHD = coronary heart disease; SES = socioeconomic status. Causal Chains of Cardiovascular Disease and Prevention Modified based on the WorldHealth Report 2002—Reducing Risks, Promoting Healthy Life.86 CHD = coronary heart disease; SES = socioeconomic status. Lifestyle and Environment Improvement Since the 1990s, rapid urbanization and industrialization in China have profoundly reshaped people's lifestyles and environment.3 Over the past decade, the corresponding policies have also exerted an increasingly significant influence. Promoting healthy lifestyles China has made substantial efforts to promote healthy lifestyles over the past 2 decades; however, there remains significant room for improvement. First, since the World Health Organization Framework Convention on Tobacco Control came into effect in China in 2006, notable progress has been made in monitoring tobacco use, implementing prevention policies, and conducting antitobacco media campaigns. However, progress in the other 4 monitor, protect, offer, warn, enforce and raise strategies has been limited.4 Second, although reducing the harmful use of alcohol has been included in national health action plans since 2016, these efforts are still in the early stages. China's alcohol tax rate is relatively low, particularly for high-alcohol-content products. Additionally, strict limitations on alcohol advertising are lacking, and regulations concerning new alcohol marketing methods and underage drinking is insufficient.5,6 Third, national programs and initiatives have been launched to address dietary habits, physical activity, and weight management. Among the most influential is the National Healthy Lifestyle Initiative, which promoted the goal of “taking 10,000 steps per day, balancing diet and exercise” during the first phase (2007-2016). In its second phase (2017-2025), the initiative advocates for the reduction of oil, salt, and sugar intake, as well as the maintenance of good oral hygiene, optimal body weight, and bone health. Building on this foundation, a 3-year campaign titled “Weight Management Year” was launched in 2024, focusing on dietary habits, physical activity, sleep, and mental health, with the goal of establishing “15-minute fitness zones” in communities nationwide by 2025.7 Meanwhile, several guidelines on healthy lifestyles have been issued to facilitate the standardization of lifestyle interventions (Supplemental Table 2). The secular trends in healthy lifestyles have been suboptimal. Overall, the prevalence of nonsmoking has shown little change (Figure 2). Among men, a slight decrease in the prevalence of current smoking was noted (from 67% in 2004 to 50% in 2018), accompanied by a minor increase in the average number of cigarettes smoked daily (from 15.5 in 2015 to 16.2 in 2018). In contrast, the prevalence of current smoking among women has remained low. The smoking cessation rate has increased slightly, from 19% in 2015 to 21% in 2018, with a more significant rise observed among female smokers.8 Meanwhile, the prevalence of alcohol consumption among adults has declined, from 38% in 2004 to 28% in 2018. However, at the same time, rural populations experienced a substantial rise in harmful drinking, with its prevalence doubling from 8% to 16%.9,10 There have been some modest dietary improvements among the Chinese population over the past few decades, including a decrease in sodium intake and an increase in the consumption of vegetables, fruits, nuts, marine omega-3 fatty acids, and polyunsaturated fatty acids.10 Nevertheless, the westernization of dietary patterns remains evident, characterized by increased consumption of red meat, processed meats, and sugar-sweetened beverages. The proportion of energy intake from fat has continued to rise, with rural areas experiencing a more rapid increase than urban areas. Between 2015 and 2017, 64% of individuals derived more than 30% of their energy intake from fat, with 71% in urban areas and 59% in rural areas.11 A decline in physical activity levels was observed among Chinese adults from 2015 to 2018, accompanied by an increase in time spent on sedentary behaviors.10,12 These changes were more pronounced in rural areas compared to urban areas. Meanwhile, leisure-time exercise remained low among Chinese adults.13 As a consequence of excessive energy intake and a sedentary lifestyle, the prevalence of overweight (23% in 2004 to 41% in 2018) and obesity (3% in 2004 to 8% in 2018) has continued to rise, except among urban women, whose prevalence has tended to plateau. Additionally, urban men exhibited a higher prevalence of overweight and obesity than their rural counterparts (25.1 kg/m2 vs 24.5 kg/m2), whereas the opposite trend was observed in women (23.9 kg/m2 vs 24.3 kg/m2).14Figure 2Secular Trends of Cardiovascular Health-Related Lifestyle FactorsSecular trends in lifestyle risk factors, stratified by sex and urbanity, show significant changes over time. The size of dots is proportional to the prevalence of the corresponding risk factor in 2018. These data were sourced from the Reports on Chronic Disease Risk Factor Surveillance in China, published by the China Center for Disease Control and Prevention.87, 88, 89, 90 Secular Trends of Cardiovascular Health-Related Lifestyle Factors Secular trends in lifestyle risk factors, stratified by sex and urbanity, show significant changes over time. The size of dots is proportional to the prevalence of the corresponding risk factor in 2018. These data were sourced from the Reports on Chronic Disease Risk Factor Surveillance in China, published by the China Center for Disease Control and Prevention.87, 88, 89, 90 In addition to the diverse patterns of geographical distribution of behavioral risk factors (Supplemental Figure 3), there are increasing disparities in the maintenance of healthy lifestyles among different sociodemographic groups in China. This indicates the influence of social determinants and highlights potential priorities for CVD prevention. In contrast to smoking, a higher prevalence of current alcohol consumption was observed among urban residents (43% vs 39%) and those with higher education (tertiary or higher: 47% vs secondary: 44% vs primary: 38% vs illiterate or below primary: 27%) and income (>60,000 yuan: 48% vs 30,000-60,000 yuan: 43% vs 15,000-30,000 yuan: 39% vs ≤15,000 yuan: 35%); however, the average daily alcohol intake was lower among these subgroups.15 A previous study based on a nationwide cohort first noted that in urban districts, areas with a higher per capita gross domestic product exhibited a lower prevalence of smoking and alcohol consumption. Conversely, in rural counties, the opposite trend was observed: a higher per capita gross domestic product was associated with increased risks related to tobacco and alcohol use. This suggests the complexity of population behavior, which involves a seeming contradiction arising from socioeconomic development—greater purchasing power facilitates access to harmful habits, whereas increased health literacy encourages avoidance of them. Additionally, low intake of vegetables and fruits was linked to lower levels of education, income, and health literacy.16 Higher levels of education and income were associated with reduced occupational and domestic physical activity.17 The relationship between educational attainment and the prevalence of overweight and obesity demonstrated sex heterogeneity: among men, higher educational attainment was associated with a higher mean body mass index and obesity prevalence, whereas the opposite trend was observed in women.14 Avoiding air pollution hazard A growing body of epidemiologic and clinical evidence has demonstrated the detrimental effects of environmental air pollution on cardiovascular health. In China, particulate matter (PM) pollution is the fourth leading risk factor for mortality and disability-adjusted life years.18 The Chinese government has implemented a range of active measures, including policies, regulations, standards, and action programs. After years of sustained efforts, the overall ambient air quality in China has improved significantly. The average annual concentration of ambient PM2.5 decreased from 72 μg/m3 in 2013 to 30 μg/m3 in 2023. Meanwhile, other pollutants have also demonstrated significant downward trends, with the exception of ozone, which has also been linked to metabolic disorders and CVD mortality recently (Figure 3). However, challenges persist, because the air quality guideline targets recommended by the World Health Organization have yet to be met.Figure 3Average Annual Concentrations of Major Ambient Pollutants in ChinaConcentrations of particulate matter with an aerodynamic diameter ≤10 μm (PM10) or ≤2.5 μm (PM2.5), NO2, and SO2 exhibited a declining trend, which intensified subsequent to the enactment of major national policies. Conversely, O3 concentrations remained relatively stable. Data came from China’s Ministry of Environmental Protection issued the Report on the State of Ecological Environment in China (2013-2021). PM10 =91 Average Annual Concentrations of Major Ambient Pollutants in China Concentrations of particulate matter with an aerodynamic diameter ≤10 μm (PM10) or ≤2.5 μm (PM2.5), NO2, and SO2 exhibited a declining trend, which intensified subsequent to the enactment of major national policies. Conversely, O3 concentrations remained relatively stable. Data came from China’s Ministry of Environmental Protection issued the Report on the State of Ecological Environment in China (2013-2021). PM10 =91 In addition to the government’s preventive and control measures, individual protection and intervention measures also serve as practical methods to mitigate the adverse effects of air pollution. Randomized crossover trials in both Chinese healthy volunteers and patients with CVD have demonstrated that short-term use of disposable particulate-filtering respirators may yield cardiovascular benefits by improving autonomic nervous function, lowering blood pressure, and reducing airway inflammation.19,20 As public awareness of the health hazards associated with air pollution has increased, convenient individual protection strategies, such as air purifiers and masks, have gradually gained popularity. Indoor air pollution resulting from the use of solid fuels for cooking and heating in the rural Chinese population has been associated with an increased risk of incident cardiovascular events and all-cause mortality.21 To address this issue, the government has accelerated the transition to clean energy for rural household heating. In 2017, the State Council issued the Clean Heating Plan for Northern China in Winter for 2017-2021, formally established the target of substituting 60% of residential solid fuels with electricity or pipeline-based natural gas for heating in northern China.22 By the end of 2020, this rate had already reached 65%, leading to a substantial reduction in PM2.5 exposure among rural populations in the region. Furthermore, air purifiers integrated into building ventilation and air conditioning systems, as well as portable, stand-alone air purifiers, are expected to effectively reduce indoor PM2.5 concentrations and provide subclinical cardiopulmonary health benefits.23,24 These measures are also anticipated to be applicable in countries like China, where urbanization is ongoing. In terms of passive smoking, the proportion of nonsmokers exposed to secondhand smoke declined from 72.4% in 2010 to 68.1% in 2018.25 Additionally, a meta-analysis indicated a downward trend in the prevalence of passive smoking among community-based populations in China since 2010, which may be attributed to the enforcement of relevant regulations.26 In 2011, the Implementation Rules on the Regulations for Public Places Sanitation Administration, issued by the National Health Commission, were amended to prohibit smoking in indoor public areas. However, the absence of specific penalties limited the effectiveness of this implementation. In 2020, the Law on Basic Medical and Health Care and the Promotion of Health, issued by the State Council, incorporated tobacco control into national legislation for the first time. This law explicitly banned smoking in indoor public places, workplaces, and public transport vehicles, thereby establishing a foundation for nationwide tobacco control legislation. Preventive Care Public health services and clinical management for CVD prevention have become more accessible, affordable, and equitable in China, primarily due to the health care reform initiated in 2009. However, the quality of care and patient outcomes still require further improvement. Primary prevention With the rapid changes in behavioral determinants of cardiovascular health, metabolic risk factors, including high blood pressure and dyslipidemia, have increasingly affected the Chinese population,27,28 leading to a growing number of high-risk individuals who require primary prevention. To optimize the limited medical resources available for preventing CVD in China's vast population, it is prudent to implement risk-based prevention strategies that prioritize individuals who would benefit the most. Based on traditional and genetic cardiovascular risk prediction models developed for the Chinese population,29, 30, 31 a guideline has been issued to promote standardized risk assessment.32 Subsequently, web-based risk estimators were created to raise awareness and disseminate knowledge among the general public. More importantly, since 2014, the Chinese government has been funding a nationwide population-based screening and intervention project,33 enrolling 10,000-20,000 individuals in each province annually. A stepwise screening strategy was employed to reduce costs and ensure feasibility. In the first step, a simple interview regarding lifestyle and medical histories, along with measurements of blood pressure, lipids, and glucose, was conducted to identify individuals at high risk for CVD. In the second step, an extended interview and examinations—including electrocardiography, carotid ultrasound, and echocardiogram—were performed only for those identified as high risk. At each site, the local Center for Disease Control and Prevention, county hospitals, and primary care institutions collaborated to fulfill their respective roles. Based on this screening strategy and division of labor, the project aims to develop a sustainable and generalizable model of public health service for all citizens in the future. To enhance the management of blood pressure, the leading CVD risk factor in China, the country launched the BPHS in 2009. This initiative provides government-funded blood pressure measurements for residents aged 35 years and older, along with annual health check-ups and 4 follow-up visits per year for individuals diagnosed with hypertension in the community. The number of patients with hypertension who received regular follow-up care through the BPHS almost tripled from 42 million in 2010 to 115 million in 2024, representing nearly one-half of the hypertensive population.34 This national initiative has been associated with a 10.3% increase in the hypertension treatment rate and a 7.9% increase in the control rate.35 Furthermore, researchers have focused on developing hypertension management strategies and tools tailored to the specific context of China. Studies have demonstrated that various interventions, such as village doctor–led multifaceted interventions,36 workplace-based multicomponent interventions,37 heart-healthy cuisine-based diets,38 and salt substitution,39, 40, 41, 42 have been effective in reducing blood pressure levels and preventing cardiovascular events. Additionally, digital tools for clinical decision support and care quality assessment in primary care institutions, as well as home-based blood pressure monitoring and medication reminders, are gaining increased attention.43 In contrast, the management of blood lipids presents greater challenges. The Chinese Guidelines have continuously updated the target levels for low-density lipoprotein cholesterol (LDL-C) based on CVD risk assessments and have recommended medications in accordance with emerging evidence. Statins were included in the first version of the National Essential Drug List in 2009, and their prices were significantly reduced due to centralized medicine procurement initiated in 2019, which improved both availability and affordability. Nevertheless, substantial gaps still exist between guideline recommendations and clinical practice. A nationwide survey involving 2.6 million middle-aged residents revealed that only 43% of individuals at high risk for CVD achieved the LDL-C target. Among those who did not meet the goal, a mere 5% were using lipid-lowering medications.44 One plausible explanation for these gaps is that primary care providers, who should play a central role in coordinating long-term care needs, have only been able to fulfill a limited function. A nationwide survey conducted between 2016 and 2017 found that over 95% of village clinics were unable to provide blood lipid tests,45 and the availability of evidence-based lipid-lowering medications in primary care institutions was insufficient.44 Moreover, although BPHS has largely facilitated equitable access to care in primary prevention, disparities in service capacity and quality persist across regions, particularly between urban and rural areas. For instance, a survey on atrial fibrillation (AF) management among elderly individuals in rural China revealed that only 7.3% of village doctors reported familiarity with integrated care for AF management. Correspondingly, among local AF patients with diagnosed hypertension and diabetes, the control rate remains approximately 10%.46 To address the shortage of skilled health care personnel in rural settings, mobile health technologies have been employed as a critical tool and have demonstrated enhanced adherence and improved clinical outcomes,47,48 indicating greater potential compared to traditional models of staff training and patient education.49 Secondary prevention During the past 2 decades, the prescription of medications for the secondary prevention of CVD has significantly improved due to expanded health insurance coverage and advancements in medical care in China. However, long-term adherence to these treatments remains suboptimal. In terms of in-hospital management, the utilization of secondary prevention medications has significantly increased among patients with established atherosclerotic CVD over the past 2 decades.50 Furthermore, the China Acute Myocardial Infarction Registry reported that nearly all of the 16,228 patients with ST-segment elevation myocardial infarction received antiplatelet agents and statins at discharge.51 Additionally, the Third China National Stroke Registry, which included 9,022 patients with ischemic stroke and transient ischemic attack, demonstrated that 95% and 93% of eligible patients received antithrombotic treatment and statins at discharge, respectively.52 For long-term management, compliance tends to decline over time following discharge.53 A recent nationwide, population-based study involving 74,830 patients diagnosed with CVD reported that the usage rate of antiplatelet agents or statins was 34.2%. Specifically, 31.5% of patients were taking only antiplatelet agents, 11.0% were taking only statins, and 8.3% were taking both.54 The usage rates of antiplatelet drugs and statins were nearly 3 times and 8 times higher, respectively, than the rates reported in previous studies conducted prior to the implementation of health care reform in 2009.55 However, these usage rates remain significantly lower than those in high-income countries, where rates exceed 60% for both medications.56 Significant disparities in medication use for secondary prevention were observed between rural and urban areas, as well as among different population subgroups (eg, age, sex, education level). The usage rate in urban areas was higher than in rural areas.54 Patients who were female, younger, had lower education levels, or experienced longer disease durations (≥2 years) exhibited lower usage rates compared to their counterparts.54,57 Additionally, disparities were noted between patients with stroke and those with coronary heart disease; patients diagnosed with stroke were less likely to be taking secondary prevention medications compared to those with coronary heart disease.58 Recommendations Fourteen ministries of the Chinese government jointly issued the implementation plan during 2023-2030 for CVD control in the Healthy China initiative.59 The plan highlights 6 strategies: 1) controlling risk factors; 2) improving health literacy; 3) strengthening comprehensive monitoring; 4) enhancing early intervention; 5) improving care quality; and 6) bolstering targeted research. In particular, in this new era characterized by an aging population, rising societal expectations,60 and advancing technologies, several specific recommendations should be considered, based on the evidence summarized herein, to optimize both individual and societal returns on investment. Fostering supportive social environments for healthy behaviors Social environment, including built environment, socioeconomic status, and social networks, is able to affect lifestyles shaped by personal preferences.61 Thus, it is essential for promoting health behavior adherence in the overall population, also for reducing disparities in the adherence between groups of different socioeconomic status, thus warrants more attention. In the Healthy China initiative, governments at various levels have proposed integrating health into all policy sectors, and multiple departments have become involved.62 To promote healthy behaviors, the government could consider a range of policy options related to social environment, such as increasing the availability of public sports facilities with little or no fees, mandating the use of nutrition fact labels that indicate the health effects of ingredients, as well as promoting healthy dietary standards in restaurants, school canteens, workplace cafeterias, and nursing homes. However, more importantly, raising taxes and prices on tobacco and alcohol products is urgently needed. The tobacco tax in China, currently at 54%, is considered intermediate on an international scale—higher than in the United States (40%) but lower than in the United Kingdom (79%)—but the price adjusted for purchasing power parity remains relatively low, and affordability has even increased over the past few decades.63 China also has a relatively low tax rate on alcohol, with a value-added tax of 17% and an excise tax of 20% on liquor.5 Additionally, there is no legal minimum price for alcohol. Taxation should not only focus on enhancing production, sales, and tax revenue, but also serve as a mechanism to mitigate harmful consumption. Given that all tobacco enterprises and most wine enterprises are state-owned, China has the potential to establish robust administration of tobacco and alcohol control and effectively leverage fiscal policy instruments. Population-level interventions aimed at improving health literacy are crucial for promoting health-related social environments. Leading institutions for CVD prevention should prioritize the development and maintenance of knowledge bases that include evidence-based, accessible, and practical educational materials. Additionally, targeted communication channels tailored to diverse populations—such as schools, workplaces, communities, and online platforms—should be established. The health institutions and professionals should be encouraged to utilize social networks with billions of active users, such as WeChat and Douyin (known as TikTok in China). This engagement should include: 1) captivating short videos or live broadcasts that provide vivid content and high interactivity; 2) targeted algorithmic recommendations that improve the efficiency of content dissemination; and 3) real-time feedback analysis that aids in understanding user needs and refining communication strategies. This presents great opportunities for outreach and education. Expanding scope of services by primary care providers Primary care facilities are well positioned to deliver integrated and continuous care. Since the health care reform in 2009, their capacity to help prevent many leading causes of death and disability has been significantly enhanced. On one hand, China has prioritized the development of the primary care infrastructure, which has further improved the availability and affordability of services.64 On the other hand, the management of hypertension and type 2 diabetes, along with elderly health management as part of the national BPHS, has facilitated CVD prevention within the community. Building on these advancements, primary care should be more broadly expanded for CVD prevention. First of all, the BPHS could consider incorporating blood lipid management, because high LDL-C has emerged as one of the leading risk factors for CVD in China. A modeling study based on a nationwide cohort in China found that nearly one-fifth of adults at moderate CVD risk and three-fifths of those at high risk failed to meet their respective LDL-C targets. Prescribing moderate-intensity statins for these individuals as recommended by current guidelines, with an estimated annual cost of $2.4 billion, could potentially prevent 264,170 cardiovascular events.65 In adjusting the dosage, managing compliance, and monitoring adverse reactions during this process, BPHS provided by primary care institutions can play a significant role due to its widely accessible services and regular follow-up visits. In 2020, the China National Center for Cardiovascular Diseases launched the Co-management for Hypertension, Hyperglycemia, and Hyperlipidemia project, which focused on risk control at the primary care institutions. In the 14 sites included in the pilot stage, this project explored the effective management mode and network. To expand the scope of practice in primary care, the most pressing need is a sufficient primary care workforce with adequate capabilities. Over the past decade, more than 200,000 general practitioners have completed standardized training programs based on national guidelines,66 bringing the total to 300,000. However, this number remains insufficient given the 980,000 primary care institutions in China. New approaches should be considered to enhance in-service education. For instance, a series of short videos delivered via mobile internet could increase the flexibility of training for the primary care workforce, which often has only fragmented time available to take courses. On the Yun-que platform established by the National Primary Health Care Hypertension Management Office in China, more than 2.2 million physicians from 400,000 primary care institutions have registered for the training program within 2 years. Personalized training modules are developed based on a precourse assessment, and 1.8 million physicians have been certified after successful completion. Leveraging new technologies to develop scalable tools Novel technologies, including mobile internet, artificial intelligence (AI), cloud computing, and the Internet of Things, have the potential to create scalable tools that facilitate the delivery of CVD prevention services and empower both the demand and supply sides. These tools are expected to generate and disseminate knowledge rapidly and extensively in an unprecedented manner, enabling them to address the inadequacies in the current health care infrastructure and workforce, as well as the shortages in traditional service models. New technologies have the potential to enhance CVD prevention at nearly every stage. For example: 1) Health education can be customized for specific individuals based on their big-data risk profiles, in which AI generated content has recently demonstrated significant potential to provide tailored and even dynamic training materials.67 2) Information disseminated within social networks can attract broader attention and raise health awareness among hard-to-reach populations, through independent cascade or linear threshold models.68 3) Wearable devices can facilitate continuous monitoring of individual health and risk status such as AF, thereby incorporating with management strategy to improve clinical outcomes.69,70 4) AI can improve clinical decision support algorithms by extracting insights from previous medical documents and conducting comparative effectiveness research based on everyday practice,71 in addition to the latest clinical guideline recommendations. China is ideally positioned to demonstrate how technology can enhance the performance of its health care system. The implementation of these technologies has made the establishment of a learning health system in China a reality. In this system, the best evidence is generated automatically through not only comprehensive data collection, but also targeted analyses that address questions arising from real-world needs, with interpretations grounded in real-world contexts. Additionally, this evidence is disseminated rapidly, allowing every physician to benefit from the collective experiences of all, and ensuring that every decision is informed by knowledge generated from the previous day. To accomplish this, both technology vendors and users must commit to the development and rigorous evaluation of strategies, whereas authorities should coordinate efforts and local experiments to identify best practices and continuously refine methodologies based on the insights obtained. Nevertheless, several barriers must be acknowledged in the utilization of new technologies, particularly in the context of AI.72 First, the majority of AI tools have not undergone rigorous randomized controlled trial evaluations. Second, there are ongoing concerns regarding privacy and trust given the “black box” nature of AI. Third, algorithmic biases may exacerbate disparities in care due to the inherent biases in the data. Finally, the implementation costs associated with AI may be prohibitively high for some health care systems. Targeting vulnerable groups in lifestyle adherence and care access Socioeconomically disadvantaged populations disproportionately face a higher risk of CVD, because they have less access to health resources and a lower likelihood of engaging in healthy lifestyles.73 China has made significant investments and achieved considerable progress in establishing an equitable health system for all through enhancements to social health insurance and BPHS, but disparities based on sex, socioeconomic status, residency, and ethnicity persist. Moreover, in light of various indicators related to lifestyle adherence, targeted interventions are still necessary for vulnerable groups. Particular attention should be given to sex-specific risk profiles. Despite the inherently advantageous status of women regarding CVD risk,74,75 studies in individuals with elevated CVD risk indicate that women exhibit fewer behavioral risk factors,76 yet possess higher levels of metabolic risk factors than their male counterparts.57,77 Additionally, every woman is expected to undergo physiological changes during her perimenopausal period,78, 79, 80, 81 leading to metabolic abnormalities and an increased risk of CVD. Therefore, targeted research is essential to develop sex-specific risk monitoring and management strategies. Specifically for women, greater emphasis should be placed on enhancing early screening and management of blood pressure, lipids, and glucose, because the estimated high CVD risk based on established equations often manifests later than in men. For undereducated and low-income populations, it is important to recognize that behavioral risk factors are the major mediators of poor cardiovascular health.82 Therefore, in addition to long-term macro strategies, such as those implemented by governments to promote compulsory education and eradicate extreme poverty, policymakers should consider enhancing access to physical exercise facilities and affordable healthy food options in nearby neighborhoods for low-income groups. Additionally, efforts should be made to ensure that undereducated individuals can easily understand how physical activity and various types of food can affect their health. With regard to residency, large-scale urbanization and migration are increasingly blurring the boundaries of urbanity. A recent study revealed the various challenges faced by newcomers in cities and highlighted the necessity for tailored lifestyle interventions and health-promoting environments for new-urban in situ residents. Additionally, it emphasized the need for policies concerning insurance payments and the settlement of interprovincial medical treatment for rural-to-urban migrants.82 Evidence on CVD prevention in ethnic minorities is insufficient, primarily due to limitations in study scale and regional coverage. Therefore, more comprehensive research is necessary, particularly to elucidate the impact of specific living environments (eg, temperature and altitude) and traditional lifestyles (eg, dietary patterns) on their risk profiles and management.83 Integrating surveillance systems for risk and burden monitoring Continuous and systematic measurement of risk and burden is essential for the timely identification of issues, adjustment of strategies, and assessment of policies in CVD prevention. It is also vital for monitoring the progress and evaluating the achievement of goals within the Healthy China initiative. Over the past 20 years, China has developed a series of CVD-related surveillance systems that focus on the prevalence and management of cardiovascular risk factors, as well as the incidence and mortality of related diseases (see Milestones of cardiovascular disease prevention in China in the Supplemental Appendix). However, these systems are somewhat fragmented. Therefore, the engagement of key stakeholders and the integration of existing systems are essential for establishing a surveillance framework that encompasses all health care institutions, the entire population, and the complete lifecycle in China. For the assessment of cardiovascular risk factors, there are 2 distinct surveillance systems: 1) the China Chronic Disease and Risk Factor Surveillance, which has been operated by the Chinese Center for Disease Control and Prevention since 2004;84 and 2) the China Cardiovascular Disease and Risk Factor Surveillance, managed by the China National Center for Cardiovascular Diseases since 2020. Both systems are based on nationally representative samples, and conduct a cross-sectional survey approximately every 5 years. The 2 leading institutions should coordinate their efforts by employing similar data collection methods and indicator definitions, thereby creating a unified system that can provide descriptions and track trends in risk factors every 2-3 years. More importantly, for the incidence of CVD, which has previously lacked comprehensive monitoring, the new estimation methods and surveillance framework recommend integrating data from various sources to mutually supplement and verify one another (Figure 4). The sites of active surveillance networks at the national level (400 randomly sampled counties and districts across 31 provinces) and provincial level (all counties and districts in 14 provinces) should be merged to provide broader coverage and improved representativeness. Also, a passive surveillance platform should be established, incorporating inpatient events related to major CVD from the Hospital Quality Monitoring System and health insurance claims data, as well as CVD deaths occurring outside of hospitals from the National Mortality Registration Information Management System.85 Nevertheless, the limitation of active surveillance is that it only covers part of the nation, whereas the drawback of passive surveillance systems is that they cannot include incident cases in primary care institutions. Therefore, models should be developed within the active surveillance networks to assess the completeness of administrative claims data in capturing all incidence events, thereby yielding more accurate incidence estimates for other regions or nationwide using only administrative claims data.Figure 4Cardiovascular Mortality and Incidence Estimation by Integrating Surveillance SystemsActive surveillance provides complete data through national and provincial cardiovascular disease (CVD) incident surveillance, and passive surveillance provides comprehensive data through Hospital Quality Monitoring System (HQMS), health insurance data, and National Mortality Registration Information Management System (NMRIMS). These data can be integrated into a modeling framework to enhance the accuracy of estimations. CDC = Center for Disease Control and Prevention; NCCD = National Center for Cardiovascular Diseases; NHC = National Health Commission; NHSA = National Healthcare Security Administration; other abbreviations as in Figure 1. Cardiovascular Mortality and Incidence Estimation by Integrating Surveillance Systems Active surveillance provides complete data through national and provincial cardiovascular disease (CVD) incident surveillance, and passive surveillance provides comprehensive data through Hospital Quality Monitoring System (HQMS), health insurance data, and National Mortality Registration Information Management System (NMRIMS). These data can be integrated into a modeling framework to enhance the accuracy of estimations. CDC = Center for Disease Control and Prevention; NCCD = National Center for Cardiovascular Diseases; NHC = National Health Commission; NHSA = National Healthcare Security Administration; other abbreviations as in Figure 1. Conclusions In China, cardiovascular health promotion and disease prevention has garnered increasing attention and investment. Whereas promising progress has been made in the environmental sector, lifestyle changes remain complex. Access to preventive care is improving; however, the quality of care is not uniformly high. Furthermore, given the suboptimal adherence to healthy lifestyles and secondary prevention measures, collaborative efforts are essential, with individuals taking primary responsibility for their own health (Central Illustration). We present a series of recommendations that encompass various domains, including policies and technologies. With successful implementation of these initiatives, China could serve as a model for developing countries facing similar challenges related to CVD.Central IllustrationProgress, Challenges, and Strategies for Cardiovascular Disease Prevention in ChinaThe model for cardiovascular disease management is shifting. Although some progress, in health promotion focused on behavioral and environmental risk factors, as well as primary and secondary prevention, has been made, unresolved challenges remain. Under the Healthy China initiative, future management frameworks advocate for integrating health into all policy sectors, and emphasizing that individuals should take primary responsibility for their own health. CVD = cardiovascular disease. Progress, Challenges, and Strategies for Cardiovascular Disease Prevention in China The model for cardiovascular disease management is shifting. Although some progress, in health promotion focused on behavioral and environmental risk factors, as well as primary and secondary prevention, has been made, unresolved challenges remain. Under the Healthy China initiative, future management frameworks advocate for integrating health into all policy sectors, and emphasizing that individuals should take primary responsibility for their own health. CVD = cardiovascular disease. Funding Support and Author Disclosures This project was partly supported by the National High Level Hospital Clinical Research Funding (2025-GSP-GG-2), the Chinese Academy of Medical Sciences Innovation Fund for Medical Science (2021-1-I2M-011), the 111 Project from the Ministry of Education of China (B16005), and the China-WHO Biennial Collaborative Projects 2022-2023 (GJ2-2022-WHOSO-07). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.